frog |
LDLo |
parenteral |
200mg/kg (200mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: STIFFNESS
CARDIAC: OTHER CHANGES |
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 166, Pg. 437, 1932. |
frog |
LDLo |
unreported |
500mg/kg (500mg/kg) |
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) |
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 164, Pg. 346, 1932. |
guinea pig |
LD50 |
intravenous |
7700ug/kg (7.7mg/kg) |
? |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 170, Pg. 461, 1967. |
mouse |
LD50 |
intraperitoneal |
15300ug/kg (15.3mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Farmakologiya i Toksikologiya Vol. 20(4), Pg. 32, 1957. |
mouse |
LD50 |
intravenous |
10mg/kg (10mg/kg) |
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE |
Journal of Pharmacology and Experimental Therapeutics. Vol. 119, Pg. 541, 1957. |
mouse |
LD50 |
oral |
3gm/kg (3000mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. |
mouse |
LD50 |
subcutaneous |
170mg/kg (170mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. |
rat |
LD50 |
intravenous |
22mg/kg (22mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. |
rat |
LD50 |
oral |
2500mg/kg (2500mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. |
rat |
LD50 |
subcutaneous |
250mg/kg (250mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. |